Announcements Trials
Browse Landscape

Phase

Phase 1 9Phase 1/2 5Phase 2 3Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 13Lymphoid 2Thoracic 1Plasma cell 1Myeloid 1Breast 1

Conditions

Multiple Myeloma 1

Interventions

Cyclophosphamide 20fludarabine phosphate 14Peripheral Blood Stem Cell Transplantation 13Dexamethasone 13Cyclosporine 12Whole-Body Irradiation 11fludarabine 10Exercise 10Antilymphocyte Serum 10Melphalan 9Busulfan 9Blood Specimen Collection 9Mycophenolic Acid 8Therapeutics 7Filgrastim 7Bortezomib 7Standard of Care 6Radiotherapy 6Behavior Therapy 6Acupuncture Therapy 6pomalidomide 5Specimen Handling 5Palliative Care 5Methotrexate 5Granulocyte Colony-Stimulating Factor 5Etoposide 5Educational Status 5daratumumab 4Surveys and Questionnaires 4Stem Cell Transplantation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Azacitidine × Plasma cell × Clear all
NCT01050790 2018-06-26

Lenalidomide + Azacitidine for Adaptive Immunotherapy -> Auto SCT in Multiple Myeloma

Virginia Commonwealth University

Phase NA Completed
17 enrolled 14 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡